|
1
|
Fang JH, Zhou HC, Zeng C, Yang J, Liu Y,
Huang X, Zhang JP, Guan XY and Zhuang SM: MicroRNA-29b suppresses
tumor angiogenesis, invasion, and metastasis by regulating matrix
metalloproteinase 2 expression. Hepatology. 54:1729–1740. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tu K, Zheng X, Zhou Z, Li C, Zhang J, Gao
J, Yao Y and Liu Q: Recombinant human adenovirus-p53 injection
induced apoptosis in hepatocellular carcinoma cell lines mediated
by p53-Fbxw7 pathway, which controls c-Myc and cyclin E. PLoS One.
8:e685742013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xu Q, Liu X, Zheng X, Yao Y, Wang M and
Liu Q: The transcriptional activity of Gli1 is negatively regulated
by AMPK through Hedgehog partial agonism in hepatocellular
carcinoma. Int J Mol Med. 34:733–741. 2014.PubMed/NCBI
|
|
4
|
Xu Q, Liu X, Zheng X, Yao Y and Liu Q:
PKM2 regulates Gli1 expression in hepatocellular carcinoma. Oncol
Lett. 8:1973–1979. 2014.PubMed/NCBI
|
|
5
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sun Y, Zhao X, Zhou Y and Hu Y: miR-124,
miR-137 and miR-340 regulate colorectal cancer growth via
inhibition of the Warburg effect. Oncol Rep. 28:1346–1352.
2012.PubMed/NCBI
|
|
7
|
Christofk HR, Vander Heiden MG, Harris MH,
Ramanathan A, Gerszten RE, Wei R, Fleming MD, Schreiber SL and
Cantley LC: The M2 splice isoform of pyruvate kinase is important
for cancer metabolism and tumour growth. Nature. 452:230–233. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang W, Xia Y, Hawke D, Li X, Liang J,
Xing D, Aldape K, Hunter T, Alfred Yung WK and Lu Z: PKM2
phosphorylates histone H3 and promotes gene transcription and
tumorigenesis. Cell. 150:685–696. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gao X, Wang H, Yang JJ, Liu X and Liu ZR:
Pyruvate kinase M2 regulates gene transcription by acting as a
protein kinase. Mol Cell. 45:598–609. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang W and Lu Z: Regulation and function
of pyruvate kinase M2 in cancer. Cancer Lett. 339:153–158. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rosa A and Brivanlou AH: MicroRNAs in
early vertebrate development. Cell Cycle. 8:3513–3520. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Harfe BD: MicroRNAs in vertebrate
development. Curr Opin Genet Dev. 15:410–415. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Croce CM and Calin GA: miRNAs, cancer, and
stem cell division. Cell. 122:6–7. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Baer C, Claus R and Plass C: Genome-wide
epigenetic regulation of miRNAs in cancer. Cancer Res. 73:473–477.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jia Z, Wang K, Wang G, Zhang A and Pu P:
miR-30a-5p antisense oligonucleotide suppresses glioma cell growth
by targeting SEPT7. PLoS One. 8:e550082013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Burchard J, Zhang C, Liu AM, Poon RT, Lee
NP, Wong KF, Sham PC, Lam BY, Ferguson MD, Tokiwa G, et al:
microRNA-122 as a regulator of mitochondrial metabolic gene network
in hepatocellular carcinoma. Mol Syst Biol. 6:4022010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tsai WC, Hsu SD, Hsu CS, Lai TC, Chen SJ,
Shen R, Huang Y, Chen HC, Lee CH, Tsai TF, et al: MicroRNA-122
plays a critical role in liver homeostasis and
hepatocarcinogenesis. J Clin Invest. 122:2884–2897. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tsai WC, Hsu PW, Lai TC, Chau GY, Lin CW,
Chen CM, Lin CD, Liao YL, Wang JL, Chau YP, et al: MicroRNA-122, a
tumor suppressor microRNA that regulates intrahepatic metastasis of
hepatocellular carcinoma. Hepatology. 49:1571–1582. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu AM, Xu Z, Shek FH, Wong KF, Lee NP,
Poon RT, Chen J and Luk JM: miR-122 targets pyruvate kinase M2 and
affects metabolism of hepatocellular carcinoma. PLoS One.
9:e868722014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bai S, Nasser MW, Wang B, Hsu SH, Datta J,
Kutay H, Yadav A, Nuovo G, Kumar P and Ghoshal K: MicroRNA-122
inhibits tumorigenic properties of hepatocellular carcinoma cells
and sensitizes these cells to sorafenib. J Biol Chem.
284:32015–32027. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li C, Yang W, Zhang J, Zheng X, Yao Y, Tu
K and Liu Q: SREBP-1 has a prognostic role and contributes to
invasion and metastasis in human hepatocellular carcinoma. Int J
Mol Sci. 15:7124–7138. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tu K, Zheng X, Dou C, Li C, Yang W, Yao Y
and Liu Q: MicroRNA-130b promotes cell aggressiveness by inhibiting
peroxisome proliferator-activated receptor gamma in human
hepatocellular carcinoma. Int J Mol Sci. 15:20486–20499. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huang Y, Guo W and Kan H: TPX2 is a
prognostic marker and contributes to growth and metastasis of human
hepatocellular carcinoma. Int J Mol Sci. 15:18148–18161. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tu K, Yang W, Li C, Zheng X, Lu Z, Guo C,
Yao Y and Liu Q: Fbxw7 is an independent prognostic marker and
induces apoptosis and growth arrest by regulating YAP abundance in
hepatocellular carcinoma. Mol Cancer. 13:1102014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bolondi L, Sofia S, Siringo S, Gaiani S,
Casali A, Zironi G, Piscaglia F, Gramantieri L, Zanetti M and
Sherman M: Surveillance programme of cirrhotic patients for early
diagnosis and treatment of hepatocellular carcinoma: A cost
effectiveness analysis. Gut. 48:251–259. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang Y, Gong W, Dai S, Huang G, Shen X,
Gao M, Xu Z, Zeng Y and He F: Downregulation of human farnesoid X
receptor by miR-421 promotes proliferation and migration of
hepatocellular carcinoma cells. Mol Cancer Res. 10:516–522. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
He Z, Wu J, Dang H, Lin H, Zheng H and
Zhong D: Polo-like kinase 1 contributes to the tumorigenicity of
BEL-7402 hepatoma cells via regulation of Survivin expression.
Cancer Lett. 303:92–98. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kefas B, Comeau L, Erdle N, Montgomery E,
Amos S and Purow B: Pyruvate kinase M2 is a target of the
tumor-suppressive microRNA-326 and regulates the survival of glioma
cells. Neuro Oncol. 12:1102–1112. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shi HS, Li D, Zhang J, Wang YS, Yang L,
Zhang HL, Wang XH, Mu B, Wang W, Ma Y, et al: Silencing of pkm2
increases the efficacy of docetaxel in human lung cancer xenografts
in mice. Cancer Sci. 101:1447–1453. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Petrelli A, Perra A, Cora D, Sulas P,
Menegon S, Manca C, Migliore C, Kowalik MA, Ledda-Columbano GM,
Giordano S, et al: MicroRNA/gene profiling unveils early molecular
changes and nuclear factor erythroid related factor 2 (NRF2)
activation in a rat model recapitulating human hepatocellular
carcinoma (HCC). Hepatology. 59:228–241. 2014. View Article : Google Scholar
|
|
32
|
Ameres SL and Zamore PD: Diversifying
microRNA sequence and function. Nat Rev Mol Cell Biol. 14:475–488.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang L, Belaguli N and Berger DH: MicroRNA
and colorectal cancer. World J Surg. 33:638–646. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tazawa H, Tsuchiya N, Izumiya M and
Nakagama H: Tumor-suppressive miR-34a induces senescence-like
growth arrest through modulation of the E2F pathway in human colon
cancer cells. Proc Natl Acad Sci USA. 104:15472–15477. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jung CJ, Iyengar S, Blahnik KR, Ajuha TP,
Jiang JX, Farnham PJ and Zern M: Epigenetic modulation of miR-122
facilitates human embryonic stem cell self-renewal and
hepatocellular carcinoma proliferation. PLoS One. 6:e277402011.
View Article : Google Scholar : PubMed/NCBI
|
